Maternal and neonatal outcomes in women with preeclampsia screening program at primary healthcare centers in indonesia

Preeclampsia can cause increased neonatal mortality and serious neonatal morbidity. This study aimed to analyze the result of the preeclampsia screening program to the maternal and neonatal outcome at primary healthcare centers. A retrospective study through medical records and ultrasound records. Screening program, including anamnesis, physical examination, were Body Mass Index (BMI), Mean Arterial Pressure (MAP), Roll Over Test (ROT), and use of Doppler ultrasound. We conducted screening to 474/693 women with 308 (64.9%)/219 (36.7%) positive results with positive risk factor of 236 cases (49.8%)/378 (63.3%). In this study, 591 persons were primigravida with 200 obese pregnant women. We found 233 pregnant women with MAP >90 mmHg and as many as 140 pregnant women with ROT >15. For neonatal outcomes, we studied infants with congenital anomalies, Intra-Uterine Fetal Death (IUFD), Intra-Uterine Growth Restriction (IUGR), abortion, preterm birth, and APGAR score <7. IUFD, IUGR and premature events were respectively 1.1%, 0.19%, and 1.7% on normal Doppler Velocimetry Uterine Artery (DVUA) ultrasound compared with increased DVUA ultrasound. There were 19 pregnant women becoming preeclampsia, severe preeclampsia, and eclampsia from pregnant women screening positive preeclampsia with normal DVUA compared to 5 (0.95%) pregnant women becoming preeclampsia screening positive preeclampsia with DVUA.